Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

Related Articles by Review for PubMed (Select 15330221)

1.

Testing an APA practice guideline: symptom-targeted medication utilization for patients with borderline personality disorder.

Oldham JM, Bender DS, Skodol AE, Dyck IR, Sanislow CA, Yen S, Grilo CM, Shea MT, Zanarini MC, Gunderson EJ, McGlashan TH.

J Psychiatr Pract. 2004 May;10(3):156-61.

PMID:
15330221
2.

Pharmacotherapy of borderline personality disorder: a systematic review for publication purpose.

Bellino S, Rinaldi C, Bozzatello P, Bogetto F.

Curr Med Chem. 2011;18(22):3322-9. Review.

PMID:
21728970
3.

A comparison of UK and US guidelines for drug treatment in borderline personality disorder.

Tyrer P, Silk KR.

Int Rev Psychiatry. 2011 Aug;23(4):388-94. doi: 10.3109/09540261.2011.606540. Review.

PMID:
22026496
4.

Efficacy and tolerability of pharmacotherapies for borderline personality disorder.

Bellino S, Paradiso E, Bogetto F.

CNS Drugs. 2008;22(8):671-92. Review.

PMID:
18601305
5.

Psychopharmacology of borderline personality disorder: a review.

Cowdry RW.

J Clin Psychiatry. 1987 Aug;48 Suppl:15-25. Review.

PMID:
2886493
6.

[Borderline personality disorder, self-mutilation and suicide: literature review].

Oumaya M, Friedman S, Pham A, Abou Abdallah T, Guelfi JD, Rouillon F.

Encephale. 2008 Oct;34(5):452-8. doi: 10.1016/j.encep.2007.10.007. Epub 2008 Feb 20. Review. French.

PMID:
19068333
7.

Psychopharmacology of borderline personality disorder.

Soloff PH.

Psychiatr Clin North Am. 2000 Mar;23(1):169-92, ix. Review.

PMID:
10729938
8.

[Psychopathology and treatment of borderline personality disorder].

Bohus M, Schmahl C.

Nervenarzt. 2007 Sep;78(9):1069-80; quiz 1081. Review. German.

PMID:
17846736
9.

[Mood stabilizer in the psychopharmacotherapy of borderline personality disorder].

Gescher DM, Malevani J.

Fortschr Neurol Psychiatr. 2009 Jul;77(7):389-98. doi: 10.1055/s-0028-1109455. Epub 2009 May 19. Review. German.

PMID:
19455483
10.

[Drug therapy of patients with emotionally unstable personality].

Nissen T.

Tidsskr Nor Laegeforen. 2000 Aug 10;120(18):2135-41. Review. Norwegian.

PMID:
11006733
11.

Neuropsychobiological aspects, comorbidity patterns and dimensional models in borderline personality disorder.

Dell'Osso B, Berlin HA, Serati M, Altamura AC.

Neuropsychobiology. 2010;61(4):169-79. doi: 10.1159/000297734. Epub 2010 Mar 18. Review.

12.

Is there any drug treatment of choice for the borderline patient?

Soloff PH.

Acta Psychiatr Scand Suppl. 1994;379:50-5. Review.

PMID:
8010152
13.

Aggression in borderline personality disorder.

Látalová K, Prasko J.

Psychiatr Q. 2010 Sep;81(3):239-51. doi: 10.1007/s11126-010-9133-3. Review.

PMID:
20390357
14.

Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects.

Coccaro EF.

J Clin Psychiatry. 1998;59 Suppl 1:30-5; discussion 36-7. Review.

PMID:
9448667
15.

[Symptom-focussed drug therapy in borderline personality disorder].

Schmahl C, Bohus M.

Fortschr Neurol Psychiatr. 2001 Jul;69(7):310-21. Review. German.

PMID:
11488246
16.

Update on pharmacotherapy of borderline personality disorder.

Zanarini MC.

Curr Psychiatry Rep. 2004 Feb;6(1):66-70. Review.

PMID:
14738708
17.

Are mood stabilisers helpful in treatment of borderline personality disorder?

Crawford MJ, MacLaren T, Reilly JG.

BMJ. 2014 Sep 16;349:g5378. doi: 10.1136/bmj.g5378. Review. No abstract available.

PMID:
25228296
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk